🇺🇸 ILMN — Illumina, Inc.

Salud Mantener
← Volver

Precio actual

226,54 USD

Máx. histórico

510,54

1906 días

Split 1028:1000 del 25/06/2024

Caída desde máximo

-55,63%

Rango 52 semanas

112,65 – 309,35

Variación hoy

-4,90%

Cierre anterior

238,21

Rango de hoy

224,05 – 244,05

Volumen hoy

3.035.725

Peor caída histórica

-96,14%

01/09/2000 → 13/03/2003

Recuperado en 1595 días

Volatilidad anualizada ⓘ

56,40%

Información
Nombre completo
Illumina, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Diagnostics & Research
Empleados
8.600
PER ⓘ
37,08 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
261,60 USD (puede no estar actualizado)
Primera cotización
28/07/2000
Precio actualizado
hace 9 horas
Sobre la empresa

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem; and strategic collaboration with Integrated DNA Technologies to enable a DRAGEN, secondary analysis pipeline for IDT xGena, FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels, delivering an integrated, end-to-end solution for somatic oncology research. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2024 1028:1000
23/09/2008 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
19/11/2012 47,96 49,08 47,54 48,71 +1,29% 3,20% 1.316.354
16/11/2012 47,30 48,14 46,97 48,08 +2,42% 2,47% 1.247.786
15/11/2012 47,14 47,42 46,61 46,95 -0,37% 1,71% 1.058.840
14/11/2012 47,24 47,52 46,79 47,12 -0,53% 1,54% 1.011.655
13/11/2012 46,74 48,19 46,38 47,37 +1,00% 3,87% 1.124.221
12/11/2012 47,48 47,86 46,64 46,91 -1,25% 2,56% 918.518
09/11/2012 46,79 48,39 46,46 47,50 +1,29% 4,12% 2.029.066
08/11/2012 46,72 47,68 46,50 46,90 +0,00% 2,54% 1.319.232
07/11/2012 46,25 50,80 45,74 46,90 +1,11% 10,94% 3.712.211
06/11/2012 46,91 46,93 46,29 46,38 -1,24% 1,35% 1.152.285
05/11/2012 46,29 47,09 46,29 46,97 +0,73% 1,72% 1.274.206
02/11/2012 47,56 47,66 46,23 46,62 -2,26% 3,01% 1.377.109
01/11/2012 46,75 47,86 46,45 47,70 +3,24% 3,02% 1.961.116
31/10/2012 46,43 46,43 45,38 46,21 -0,90% 2,26% 1.375.464
26/10/2012 46,67 46,94 45,13 46,62 +0,69% 3,88% 1.931.304
25/10/2012 45,54 48,03 44,96 46,30 +3,21% 6,73% 2.928.155
24/10/2012 43,77 46,03 43,56 44,86 +2,06% 5,64% 2.172.164
23/10/2012 45,02 45,36 43,63 43,96 -3,07% 3,85% 1.554.130
22/10/2012 45,61 46,03 44,65 45,35 -0,13% 3,03% 1.628.763
19/10/2012 45,86 46,09 45,21 45,41 -0,95% 1,91% 1.470.246
18/10/2012 46,38 46,74 45,65 45,85 -1,63% 2,35% 1.060.896
17/10/2012 47,03 47,23 46,41 46,61 -0,58% 1,74% 1.140.360
16/10/2012 47,67 48,12 46,54 46,88 +0,25% 3,33% 2.281.646
15/10/2012 49,90 49,90 45,23 46,76 -6,04% 9,36% 7.302.192
12/10/2012 50,74 51,03 49,59 49,77 -2,05% 2,84% 2.658.511
11/10/2012 50,32 51,15 49,85 50,81 +2,23% 2,57% 1.512.496
10/10/2012 49,64 50,98 49,25 49,70 +0,43% 3,49% 2.047.159
09/10/2012 50,64 50,64 49,42 49,48 -2,08% 2,42% 1.545.495
08/10/2012 50,21 51,04 49,85 50,54 +0,31% 2,36% 1.536.346
05/10/2012 51,34 51,53 50,05 50,38 -0,88% 2,88% 2.063.916